Nautilus Biotechnology, Inc.

Arya Sciences Acquisition Corp III is a blank-check company focused on the healthcare and life sciences sector, sponsored by Perceptive Advisors and registered with the SEC under CIK 0001808805. The vehicle completed its IPO in 2021, targeting opportunities across biotechnology and medical innovation. The SPAC has since closed its business combination with Nautilus Biotechnology, Inc., a proteomics firm developing single-molecule protein sequencing technology designed to advance drug discovery and large-scale protein analysis. Nautilus Biotechnology now operates as a publicly traded company following the completed transaction. For full filing history, sponsor data, and deal timelines across thousands of SPACs, sign up for access at SpacDesk.

SPAC Counterparty (1)